Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211)

This page is currently under construction.


Please check back soon for a description of the ongoing research.


Back to Ongoing and Planned Research


Introduction of Sofosbuvir in Egypt

In July 2014, Gilead and the Egyptian government signed an agreement for a treatment expansion of Sovaldi® (Sofosbuvir). Read more

Scientific Advisory Board Meeting

The Scientific Advisory Board Meeting was held in Paris February 15-16, 2013.

Read more

fp7_01fp7_02 This project is funded
by the European Union